Medicines and Healthcare Products Regulatory Agency

The first respiratory syncytial virus (RSV) vaccine for elderly people, GSK's Arexvy, received approval from the Medicines and Healthcare Products Regulatory Agency

The first respiratory syncytial virus (RSV) vaccine for elderly people, GSK’s Arexvy, received approval from the Medicines and Healthcare Products Regulatory Agency

SG Tylor

Source – GSK GSK has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted ...